Einstein Experts for Media
Search Results
You searched for "Translational medicine"
3 results found
Paul R. Marantz, MD, MPH
Associate Dean, Clinical Research Education, Einstein
Associate Director, Block Institute for Clinical and Translational Research at Einstein and Montefiore
Professor, Epidemiology & Population Health, Einstein
Professor, Medicine (General Internal Medicine), Einstein
Research educationClinical research methodsPublic health
Translational medicine
Dr. Marantz is an innovator in developing educational programs in clinical medicine, research methods, and public health for medical students, residents, physicians, and other health professionals. He is co-director of Einstein’s Clinical and Translational Science Award program, a national, NIH-funded consortium working to improve patient care by reducing the time it takes for laboratory discoveries to make their way into medical practice. leer más...
Vern L. Schramm, PhD
Professor, Biochemistry
Cátedra Ruth Merns de BioquÃÂÂmica
BioquÃÂÂmicaEnzymesTranslational medicine
RicinAutoimmune diseases
Dr. Schramm is a member of the National Academy of Sciences and associate editor of the Journal of the American Chemical Society. His pioneering work in biochemistry has resulted in powerful new strategies for treating cancer, antibiotic resistance and autoimmune diseases. leer más...
Ulrich G. Steidl, Ph.D., M.D.
Professor, Cell Biology
Professor, Medicine
Deputy Director, Montefiore Einstein Comprehensive Cancer Center
Cátedra Rose C. Falkenstein de Investigación del Cáncer
Director interino del Instituto Ruth L. y David S. Gottesman para la investigación de células madre y medicina regenerativa
Leukemias and myelodysplastic syndromes Pre-cancerous and cancer stem cellsCell and tumor biology
Dr. Steidl studies the molecular and cellular mechanisms that lead to two related blood diseases, myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). His NIH-funded basic and translational research seeks to define the characteristics of pre-leukemic stem cells (pre-LSC), understand their progression to leukemic stems cells, and develop drug strategies to target the process. Dr. Steidl is co-director of the Montefiore Einstein Comprehensive Cancer Center's Blood Cancer Institute. read more...
Contacto Relaciones con los medios
Correo electrónico: noticiascientificas@einsteinmed.edu
Phone: 718.430.3101